3 Cryptos to Buy for 2022

From Investor Place Media | Ad

Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."

Just click here to claim your copy today.

RGLS Insider Trading (Regulus Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.62%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,042.78

Regulus Therapeutics Insider Trading History Chart

Regulus Therapeutics Share Price & Price History

^$0.25

▼ -0.01 (-3.89%)

As of 01/14/2022 01:00 AM ET

Days: 30 | 90 | 365

The End of Smartphones?

From Legacy Research | Ad

The Biggest Tech Companies in The World Are Quietly Preparing For "SCG"

Find out more here.

Regulus Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/17/2021	Christopher Ray Aker	VP	Sell	860	$0.89	$765.40	41,754
5/17/2021	Joseph P. Hagan	CEO	Sell	4,186	$0.89	$3,725.54	316,292
2/16/2021	Christopher Ray Aker	VP	Sell	828	$1.72	$1,424.16	42,614
2/16/2021	Joseph P. Hagan	CEO	Sell	4,144	$1.72	$7,127.68	485,756
12/4/2020	Paul Edward Walker	Major Shareholder	Buy	4,398,602	$0.62	$2,727,133.24
8/14/2020	Christopher Ray Aker	VP	Sell	872	$0.61	$531.92	26,638
8/14/2020	Joseph P. Hagan	CEO	Sell	4,245	$0.60	$2,547.00	222,088
5/15/2020	Christopher Ray Aker	VP	Sell	909	$0.63	$572.67	27,510
5/15/2020	Joseph P. Hagan	CEO	Sell	4,426	$0.63	$2,788.38	226,333
2/18/2020	Christopher Ray Aker	VP	Sell	888	$0.83	$737.04	28,419
2/18/2020	Joseph P. Hagan	CEO	Sell	4,324	$0.83	$3,588.92	230,759
1/2/2020	Christopher Ray Aker	VP	Sell	2,239	$0.97	$2,171.83	29,307
1/2/2020	Joseph P. Hagan	CEO	Sell	8,345	$0.97	$8,094.65	235,083
11/14/2019	Christopher Ray Aker	VP	Sell	833	$0.64	$533.12	31,546
11/14/2019	Joseph P. Hagan	CEO	Sell	5,838	$0.64	$3,736.32	243,428
10/1/2019	Christopher Ray Aker	VP	Sell	2,346	$0.68	$1,595.28	32,379
10/1/2019	Joseph P. Hagan	CEO	Sell	8,743	$0.68	$5,945.24	249,266
8/15/2019	Christopher Ray Aker	VP	Sell	899	$0.55	$494.45
8/15/2019	Joseph P. Hagan	Insider	Sell	4,375	$0.55	$2,406.25
7/1/2019	Christopher Ray Aker	VP	Sell	2,225	$1.31	$2,914.75	35,624
7/1/2019	Daniel R Chevallard	CFO	Sell	2,669	$1.31	$3,496.39	77,870
7/1/2019	Joseph P. Hagan	Insider	Sell	5,783	$1.31	$7,575.73	262,384
5/16/2019	Joseph P. Hagan	Insider	Sell	39,352	$1.22	$48,009.44	307,519
5/15/2019	Christopher Ray Aker	VP	Sell	6,950	$1.41	$9,799.50	66,259
5/15/2019	Daniel R Chevallard	CFO	Sell	10,000	$1.41	$14,100.00	90,539
5/7/2019	Joseph P. Hagan	CEO	Buy	33,194	$1.08	$35,849.52	64,542
5/7/2019	Pascale Witz	Director	Buy	29,630	$1.08	$32,000.40	37,849
5/7/2019	Peter J Barris	Major Shareholder	Buy	1,136,704	$1.08	$1,227,640.32
4/1/2019	Christopher Ray Aker	VP	Sell	2,710	$0.98	$2,655.80	6,287
4/1/2019	Daniel R Chevallard	CFO	Sell	3,253	$0.98	$3,187.94	9,372
4/1/2019	Joseph P. Hagan	CEO	Sell	5,842	$0.98	$5,725.16	31,348

Insider Selling at Regulus Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Regulus Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Regulus Therapeutics (NASDAQ:RGLS)

43.14% of Regulus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regulus Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2021	Morgan Stanley	564,462	$0.39M	0.0%	+13.0%	0.649%
11/15/2021	GSA Capital Partners LLP	64,708	$45K	0.0%	-68.6%	0.074%
11/12/2021	Geode Capital Management LLC	670,747	$0.46M	0.0%	+13.8%	0.771%
11/4/2021	Asymmetry Capital Management L.P.	1,401,491	$0.97M	0.6%	-3.4%	1.610%
10/29/2021	Commonwealth Equity Services LLC	111,000	$76K	0.0%	+38.8%	0.128%
9/17/2021	Virtu Financial LLC	79,193	$64K	0.0%	N/A	0.091%
8/27/2021	Endurant Capital Management LP	2,607,674	$2.12M	0.6%	+9.7%	2.996%
8/23/2021	Morgan Stanley	499,625	$0.41M	0.0%	+206.0%	0.574%
8/16/2021	Bank of America Corp DE	204,186	$0.17M	0.0%	-58.3%	0.235%
8/16/2021	Morgan Stanley	499,625	$0.41M	0.0%	+206.0%	0.574%
8/16/2021	State Street Corp	176,494	$0.14M	0.0%	N/A	0.203%
8/13/2021	Geode Capital Management LLC	589,196	$0.48M	0.0%	+54.3%	0.786%
8/13/2021	Vanguard Group Inc.	3,095,237	$2.52M	0.0%	-3.9%	4.131%
8/12/2021	Lido Advisors LLC	57,500	$47K	0.0%	N/A	0.077%
8/11/2021	Commonwealth Equity Services LLC	80,000	$65K	0.0%	+300.0%	0.107%
8/10/2021	Strategic Wealth Advisors Group LLC	74,800	$61K	0.0%	N/A	0.100%
8/5/2021	GSA Capital Partners LLP	206,265	$0.17M	0.0%	N/A	0.275%
7/31/2021	Asymmetry Capital Management L.P.	1,450,777	$1.18M	0.8%	-26.9%	1.936%
7/15/2021	Focused Wealth Management Inc	200,000	$0.16M	0.0%	+100.0%	0.267%
5/19/2021	Squarepoint Ops LLC	159,804	$0.25M	0.0%	+1,477.7%	0.213%
5/18/2021	Morgan Stanley	163,251	$0.26M	0.0%	+2,799.7%	0.218%
5/17/2021	Endurant Capital Management LP	2,376,557	$3.71M	1.0%	N/A	3.172%
5/17/2021	Ikarian Capital LLC	1,245,989	$1.94M	0.1%	N/A	1.663%
5/17/2021	Atom Investors LP	337,228	$0.53M	0.1%	N/A	0.450%
5/17/2021	Goldman Sachs Group Inc.	18,049	$28K	0.0%	-68.0%	0.024%
5/12/2021	Northern Trust Corp	117,654	$0.18M	0.0%	+198.4%	0.157%
5/12/2021	Geode Capital Management LLC	381,892	$0.60M	0.0%	+493.5%	0.510%
5/11/2021	Acadian Asset Management LLC	465,678	$0.73M	0.0%	N/A	0.622%
5/11/2021	Asymmetry Capital Management L.P.	1,985,472	$3.10M	1.6%	N/A	2.650%
5/4/2021	Commonwealth Equity Services LLC	20,000	$31K	0.0%	N/A	0.027%
5/4/2021	Victory Capital Management Inc.	2,227,199	$3.47M	0.0%	+345.4%	2.976%
5/3/2021	Focused Wealth Management Inc	100,000	$0.16M	0.0%	N/A	0.134%
2/10/2021	Renaissance Technologies LLC	449,200	$0.61M	0.0%	N/A	1.147%
2/5/2021	BlackRock Inc.	49,788	$68K	0.0%	-23.2%	0.127%
2/2/2021	Grimes & Company Inc.	54,511	$74K	0.0%	+127.1%	0.139%
2/2/2021	GYL Financial Synergies LLC	51,376	$69K	0.0%	N/A	0.131%
2/1/2021	Victory Capital Management Inc.	499,989	$0.68M	0.0%	N/A	1.277%
10/20/2020	Wedbush Securities Inc.	70,204	$36K	0.0%	+241.2%	0.193%
8/14/2020	BVF Inc. IL	1,450,000	$0.99M	0.1%	-9.0%	6.892%
8/7/2020	Virtu Financial LLC	84,348	$57K	0.0%	N/A	0.401%
5/12/2020	Rockefeller Capital Management L.P.	84,642	$39K	0.0%	-22.9%	0.402%
2/13/2020	Renaissance Technologies LLC	476,993	$0.43M	0.0%	+17.3%	2.269%
2/7/2020	Rockefeller Capital Management L.P.	109,839	$98K	0.0%	+1,547.7%	0.523%
8/16/2019	CVI Holdings LLC	454,190	$0.57M	0.5%	N/A	2.180%
8/15/2019	Jane Street Group LLC	32,449	$41K	0.0%	-48.6%	0.156%
8/14/2019	EcoR1 Capital LLC	1,111,110	$1.39M	0.1%	N/A	5.335%
8/14/2019	Samsara BioCapital LLC	904,407	$1.13M	0.7%	N/A	4.355%
8/7/2019	NEA Management Company LLC	2,052,455	$2.57M	0.2%	+124.1%	9.882%
4/17/2019	Wedbush Securities Inc.	43,489	$44K	0.0%	+32.8%	0.405%
4/12/2019	Virtu Financial LLC	66,593	$68K	0.0%	N/A	0.620%
2/13/2019	Geode Capital Management LLC	40,327	$37K	0.0%	-91.7%	0.461%
2/8/2019	BlackRock Inc.	48,817	$45K	0.0%	-91.7%	0.558%
1/31/2019	Wedbush Securities Inc.	32,738	$30K	0.0%	-79.0%	0.374%
1/18/2019	NEA Management Company LLC	915,751	$0.85M	0.0%	-91.7%	10.466%
12/13/2018	Vanguard Group Inc	2,614,704	$0.52M	0.0%	-1.5%	29.882%
11/23/2018	Vanguard Group Inc.	2,614,704	$0.52M	0.0%	-1.5%	29.882%
11/13/2018	Renaissance Technologies LLC	595,501	$0.12M	0.0%	+396.3%	6.821%
11/9/2018	FMR LLC	3,961,244	$0.78M	0.0%	-74.7%	45.375%
5/15/2018	Point72 Asset Management L.P.	737,995	$0.53M	0.0%	-35.3%	0.707%
5/15/2018	A.R.T. Advisors LLC	169,416	$0.12M	0.0%	N/A	0.162%
2/14/2018	BVF Inc. IL	13,974,249	$14.53M	1.8%	+7.9%	13.442%
2/13/2018	Renaissance Technologies LLC	137,589	$0.14M	0.0%	+215.7%	0.132%
2/13/2018	Broadfin Capital LLC	1,509,342	$1.57M	0.3%	-64.9%	1.452%
2/13/2018	Ascend Capital LLC	1,014,006	$1.05M	0.0%	N/A	0.975%
2/8/2018	Wells Fargo & Company MN	392,142	$0.41M	0.0%	-20.3%	0.377%
2/8/2018	Candriam Luxembourg S.C.A.	500,000	$0.52M	0.0%	-16.7%	0.481%
2/1/2018	Victory Capital Management Inc.	327,770	$0.34M	0.0%	+18.2%	0.315%
11/20/2017	GSA Capital Partners LLP	203,815	$0.26M	0.0%	+44.8%	0.196%
11/9/2017	Wells Fargo & Company MN	492,191	$0.62M	0.0%	-29.5%	0.474%
11/9/2017	South Dakota Investment Council	1,820,027	$2.28M	0.0%	+37.1%	1.754%
11/3/2017	Candriam Luxembourg S.C.A.	600,000	$0.75M	0.0%	N/A	0.578%
11/3/2017	NEA Management Company LLC	10,989,910	$13.74M	0.5%	N/A	10.589%
10/27/2017	Victory Capital Management Inc.	277,240	$0.35M	0.0%	N/A	0.267%
8/15/2017	EcoR1 Capital LLC	3,709,144	$3.66M	0.6%	+145.6%	3.574%
8/14/2017	Royal Bank of Canada	184,040	$0.18M	0.0%	+12.1%	0.177%
8/14/2017	Goldman Sachs Group Inc.	368,285	$0.36M	0.0%	+189.1%	0.355%
8/11/2017	California Public Employees Retirement System	177,600	$0.18M	0.0%	No Change	0.334%
8/11/2017	FMR LLC	7,977,349	$7.86M	0.0%	+0.5%	15.000%
8/11/2017	GSA Capital Partners LLP	140,715	$0.14M	0.0%	N/A	0.265%
8/11/2017	Quantitative Investment Management LLC	105,000	$0.10M	0.0%	N/A	0.197%
8/10/2017	South Dakota Investment Council	1,327,058	$1.31M	0.0%	No Change	2.495%
8/10/2017	Wells Fargo & Company MN	698,390	$0.69M	0.0%	-10.7%	1.313%
8/3/2017	LMR Partners LLP	166,307	$0.16M	0.0%	N/A	0.313%
8/2/2017	Wedbush Securities Inc.	199,521	$0.20M	0.0%	+10.3%	0.375%
5/18/2017	Goldman Sachs Group Inc.	127,395	$0.21M	0.0%	-44.2%	0.240%
5/15/2017	Tudor Investment Corp ET AL	108,061	$0.18M	0.0%	+131.5%	0.203%
5/12/2017	Renaissance Technologies LLC	118,341	$0.20M	0.0%	-63.2%	0.224%
5/12/2017	South Dakota Investment Council	1,327,058	$2.19M	0.0%	+16.3%	2.507%
5/11/2017	California Public Employees Retirement System	177,600	$0.29M	0.0%	-4.2%	0.336%
5/11/2017	TIAA CREF Investment Management LLC	123,293	$0.20M	0.0%	No Change	0.233%
5/11/2017	FMR LLC	7,939,860	$13.10M	0.0%	+0.0%	15.000%
5/5/2017	Wedbush Securities Inc.	180,921	$0.30M	0.0%	+106.8%	0.342%
5/3/2017	Bank of New York Mellon Corp	116,400	$0.19M	0.0%	-12.6%	0.220%
4/28/2017	Wells Fargo & Company MN	782,380	$1.29M	0.0%	+13.5%	1.478%
3/29/2017	Teachers Advisors LLC	72,273	$0.16M	0.0%	+15.7%	0.137%
2/14/2017	Tudor Investment Corp Et Al	46,688	$0.11M	0.0%	N/A	0.088%
2/14/2017	A.R.T. Advisors LLC	90,400	$0.20M	0.0%	+405.0%	0.171%
2/13/2017	Renaissance Technologies LLC	321,200	$0.72M	0.0%	-50.2%	0.607%
2/10/2017	FMR LLC	7,938,495	$17.86M	0.0%	+0.2%	15.000%
11/14/2016	Virtus ETF Advisers LLC	46,269	$0.15M	0.1%	No Change	0.087%

Data available starting January 2016

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The firm is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded on September 5, 2007 and is headquartered in San Diego, CA.

Today's Range

Now: $0.25

$0.23

$0.25

50 Day Range

MA: $0.35

$0.25

$0.46

52 Week Range

Now: $0.25

$0.23

$2.32

Volume

1,786,396 shs

Average Volume

1,842,120 shs

Market Capitalization

$21.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.97

Who are the company insiders with the largest holdings of Regulus Therapeutics?: Regulus Therapeutics' top insider investors include:
Joseph P Hagan (CEO)
Christopher Ray Aker (VP)
Paul Edward Walker (Major Shareholder)

[FREE Report] 5 Growth Stocks Under $49

From Motley Fool | Ad

Stay focused on the long-term with these 5 growth stock picks.

Learn More.